ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $32.5M

      Shares

      153k

      % of Portfolio

      0.55%

      Average Buy Price

      $176

      Avg closing price
      Price range

      20 Jefferies Group Abbvie Trades

      Jefferies Group acquired 153k Abbvie shares worth $32.5M. That's 0.55% of their equity portfolio (44th largest holding). The first Abbvie trade was made in Q1 2017. Since then Jefferies Group bought shares ten more times and sold shares on nine occasions. The stake costed the investor $26.9M, netting the investor a gain of 21% so far.

      Avg closing price
      Price range
      Sold 14.9% shares (-26.8k shares) Q2 2025
      Avg closing price $185.63
      Price range $170.16 - $206.27
      Increased shares by 212.9% (+122k shares) Q1 2025
      Avg closing price $193.75
      Price range $169.15 - $216.66
      Sold 81.1% shares (-246k shares) Q4 2024
      Avg closing price $183.81
      Price range $164.95 - $203.87
      Increased shares by 8.5% (+23.7k shares) Q3 2024
      Avg closing price $186.44
      Price range $163.84 - $199.35
      Increased shares by 340.1% (+216k shares) Q2 2024
      Avg closing price $165.65
      Price range $154.79 - $180.76
      New holding (+63.6k shares) Q1 2024
      Avg closing price $172.34
      Price range $159.82 - $182.10
      Sold -19.6k shares Q4 2023
      Avg closing price $145.79
      Price range $137.60 - $154.97
      Sold 5.2% shares (-1.08k shares) Q3 2023
      Avg closing price $146.80
      Price range $133.59 - $154.65
      Sold 86.9% shares (-136k shares) Q2 2023
      Avg closing price $146.64
      Price range $132.51 - $164.90
      Increased shares by 74.0% (+66.8k shares) Q1 2023
      Avg closing price $152.88
      Price range $144.61 - $166.55
      New holding (+90.3k shares) Q4 2022
      Avg closing price $153.33
      Price range $138.31 - $165.99
      Sold -17k shares Q2 2019
      Avg closing price $78.60
      Price range $65.70 - $83.98
      Sold 58.3% shares (-23.8k shares) Q1 2019
      Avg closing price $81.81
      Price range $77.14 - $90.79
      Increased shares by 1.8% (+725 shares) Q4 2018
      Avg closing price $87.94
      Price range $77.85 - $96.01
      Increased shares by 23.2% (+7.55k shares) Q3 2018
      Avg closing price $94.83
      Price range $88.91 - $98.84
      New holding (+32.5k shares) Q2 2018
      Avg closing price $97.66
      Price range $89.78 - $106.23
      Sold -5.11k shares Q1 2018
      Avg closing price $109.85
      Price range $92.01 - $123.21
      New holding (+5.11k shares) Q4 2017
      Avg closing price $94.25
      Price range $89.56 - $98.21
      Sold -8.01k shares Q2 2017
      Avg closing price $67.23
      Price range $63.45 - $73.18
      New holding (+8.01k shares) Q1 2017
      Avg closing price $62.87
      Price range $60.00 - $66.55

      News about Abbvie Inc and Jefferies Group

      Nxera Pharma Hits Milestone with AbbVie Partnership

      Nxera Pharma Hits Milestone with AbbVie Partnership

      Sosei Group (JP:4565) has released an update. Nxera Pharma has received a $10 million milestone payment from AbbVie for their collaborative effort ¡­

      TipRanks TipRanks, about 1 year ago
      Is Your Botox Real Or Fake? Counterfeit Boxes Circulate For Widely Used Antiwrinkle Treatment, CDC And FDA Investigate Harmful Reactions

      Is Your Botox Real Or Fake? Counterfeit Boxes Circulate For Widely Used Antiwrinkle Treatment, CDC And FDA Investigate Harmful Reactions

      On Tuesday, the FDA issued a warning regarding the dangers associated with counterfeit versions of AbbVie Inc¡¯s (NYSE: ABBV ) Botox used for cosmetic purpose...

      Benzinga Benzinga, over 1 year ago
      Baird Financial Group Inc. Decreases Stock Holdings in AbbVie Inc. (NYSE:ABBV)

      Baird Financial Group Inc. Decreases Stock Holdings in AbbVie Inc. (NYSE:ABBV)

      Baird Financial Group Inc. trimmed its position ¡­ about 0.8% of Baird Financial Group Inc.¡¯s investment portfolio ¡­ its 21st largest holding. Baird Financial...

      EIN News Finance EIN News Finance, almost 2 years ago
      Future Financial Wealth Managment LLC Increases Position in AbbVie Inc. (NYSE:ABBV)

      Future Financial Wealth Managment LLC Increases Position in AbbVie Inc. (NYSE:ABBV)

      ¡­ about 1.0% of Future Financial Wealth Managment LLC¡¯s holdings ¡­ its 28th largest holding. Future Financial Wealth Managment LLC¡¯s holdings ¡­ holdings of t...

      EIN News Finance EIN News Finance, almost 2 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×